ASCO vs. BIO: A Scheduling And Exhibit Hall Culture Clash
Executive Summary
The two massive conferences overlapped in early June, causing scheduling angst for some firms – and highlighting the difference between events focused on data and those focused on deal-making.
You may also be interested in...
What Does A Typical Refuse-To-File Letter Look Like?
Our infographic offers a composite sketch from a decade of US FDA data on refuse-to-file letters.
Pink Sheet Podcast: Dsuvia Warning Letter, Refuse-To-File Impact, CDER’s COVID Workload
Pink Sheet reporters and editor discuss the issues surrounding an FDA warning letter on Dsuvia promotion, an expected jump in CDER coronavirus-related workload, and a study of refuse-to-file actions.
Pink Sheet Podcast: COVID-19 variants and vaccine trial dropouts, Aducanumab, User Fee Goal Changes
Pink Sheet reporters and editor discuss the latest coronavirus vaccine news, CMS’ effect on the future of aducanumab, as well as new assessment goals for PDUFA VII.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: